APA (7th ed.) Citation

Matthaei, J., Seitz, T., Jensen, O., Tann, A., Prukop, T., Tadjerpisheh, S., . . . Tzvetkov, M. V. (2019). OCT1 Deficiency Affects Hepatocellular Concentrations and Pharmacokinetics of Cycloguanil, the Active Metabolite of the Antimalarial Drug Proguanil. Clinical pharmacology and therapeutics, 105(1), 190. https://doi.org/10.1002/cpt.1128

Chicago Style (17th ed.) Citation

Matthaei, Johannes, Tina Seitz, Ole Jensen, Annabelle Tann, Thomas Prukop, Sina Tadjerpisheh, Jürgen Brockmöller, and Mladen V. Tzvetkov. "OCT1 Deficiency Affects Hepatocellular Concentrations and Pharmacokinetics of Cycloguanil, the Active Metabolite of the Antimalarial Drug Proguanil." Clinical Pharmacology and Therapeutics 105, no. 1 (2019): 190. https://doi.org/10.1002/cpt.1128.

MLA (9th ed.) Citation

Matthaei, Johannes, et al. "OCT1 Deficiency Affects Hepatocellular Concentrations and Pharmacokinetics of Cycloguanil, the Active Metabolite of the Antimalarial Drug Proguanil." Clinical Pharmacology and Therapeutics, vol. 105, no. 1, 2019, p. 190, https://doi.org/10.1002/cpt.1128.